DrugPatentWatch Database Preview
Novast Labs Company Profile
» See Plans and Pricing
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has fifty-nine approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Summary for Novast Labs
| US Patents: | 0 |
| Tradenames: | 57 |
| Ingredients: | 42 |
| NDAs: | 59 |
Drugs and US Patents for Novast Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 210267-001 | Mar 12, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 210611-001 | Oct 30, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | MAFENIDE ACETATE | mafenide acetate | FOR SOLUTION;TOPICAL | 206716-001 | Jul 31, 2017 | AT | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
